Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SHSE:603456'
s Days Inventory Range Over the Past 10 Years
Min: 152.84 Med: 189.62 Max: 220.38
Current: 167.27
During the past 13 years, Zhejiang Jiuzhou Pharmaceutical Co's highest Days Inventory was 220.38. The lowest was 152.84. And the median was 189.62.
SHSE:603456's Days Inventory is ranked worse than 51.95% of 922
companies
in the Drug Manufacturers industry
Industry Median: 165.005
vs SHSE:603456: 167.27
Inventory Turnover measures how fast the company turns over its inventory within a year.
Zhejiang Jiuzhou Pharmaceutical Co's Inventory Turnover for the
three
months ended in Jun. 2026 was 0.58.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Zhejiang Jiuzhou Pharmaceutical Co's Inventory-to-Revenue for the
three
months ended in Jun. 2026 was 1.08.
Zhejiang Jiuzhou Pharmaceutical Co (SHSE:603456) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Zhejiang Jiuzhou Pharmaceutical Co's Inventory Turnover for the
three
months ended in Jun. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Zhejiang Jiuzhou Pharmaceutical Co's Inventory to Revenue for the
three
months ended in Jun. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Zhejiang Jiuzhou Pharmaceutical Co Days Inventory Related Terms
Zhejiang Jiuzhou Pharmaceutical Co Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zhejiang Jiuzhou Pharmaceutical Co Days Inventory Chart
For the Drug Manufacturers - Specialty & Generic subindustry, Zhejiang Jiuzhou Pharmaceutical Co's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zhejiang Jiuzhou Pharmaceutical Co Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Zhejiang Jiuzhou Pharmaceutical Co's Days Inventory distribution charts can be found below:
* The bar in red indicates where Zhejiang Jiuzhou Pharmaceutical Co's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zhejiang Jiuzhou Pharmaceutical Co (SHSE:603456) has a Days Inventory of 157.67 as of Jun. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Zhejiang Jiuzhou Pharmaceutical Co and its competitors. This is 17% below median its historical median of 189.62. Over the past decade, Zhejiang Jiuzhou Pharmaceutical Co's Days Inventory has ranged from 152.84 to 220.38. According to the industry distribution chart, Zhejiang Jiuzhou Pharmaceutical Co ranks #479 out of 922 companies in the Drug Manufacturers industry, placing it in the top 52%.
Is Zhejiang Jiuzhou Pharmaceutical Co's Days Inventory too high?
Zhejiang Jiuzhou Pharmaceutical Co's current Days Inventory of 157.67 is 17% below median its 10-year median of 189.62. Over the past 10 years, this metric has ranged from a low of 152.84 to a high of 220.38. The Drug Manufacturers industry median Days Inventory is 165.01. Zhejiang Jiuzhou Pharmaceutical Co's value of 157.67 is 4.4% below this industry median. Based on the distribution chart, Zhejiang Jiuzhou Pharmaceutical Co ranks #479 out of 922 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Zhejiang Jiuzhou Pharmaceutical Co has a GF Score™ of 95/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Zhejiang Jiuzhou Pharmaceutical Co's Days Inventory compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Zhejiang Jiuzhou Pharmaceutical Co ranks #479 out of 922 companies for Days Inventory. This places Zhejiang Jiuzhou Pharmaceutical Co in the lower half of its industry. The industry median Days Inventory is 165.01. Zhejiang Jiuzhou Pharmaceutical Co's value of 157.67 is 4.4% below this benchmark. Historically, Zhejiang Jiuzhou Pharmaceutical Co's own Days Inventory has ranged from 152.84 to 220.38 over the past decade. While the company's 10-year median is 189.62 vs. the industry median of 165.01, Zhejiang Jiuzhou Pharmaceutical Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 165.01, based on 922 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Zhejiang Jiuzhou Pharmaceutical Co's current Days Inventory of 157.67 is 4.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Zhejiang Jiuzhou Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 165.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zhejiang Jiuzhou Pharmaceutical Co's current Days Inventory is 157.67, which is 17% below median its own 10-year median of 189.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhejiang Jiuzhou Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Zhejiang Jiuzhou Pharmaceutical Co (SHSE:603456) is currently considered Fairly Valued. The stock's GF Value™ is ¥16.43, compared to a current price of ¥15.18 — trading 7.6% below its estimated fair value. The current Days Inventory is 157.67, which is 17% below median its 10-year median of 189.62 and 4.4% below the Drug Manufacturers industry median of 165.01. Zhejiang Jiuzhou Pharmaceutical Co's overall GF Score™ is 95/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Zhejiang Jiuzhou Pharmaceutical Co (SHSE:603456), the current Days Inventory is 157.67 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zhejiang Jiuzhou Pharmaceutical Co (SHSE:603456) Overvalued in 2026?
Based on GuruFocus' analysis, Zhejiang Jiuzhou Pharmaceutical Co stock appears to be undervalued.
The current stock price of ¥15.18 is trading 7.6% below its estimated GF Value™ of ¥16.43.
GuruFocus considers Zhejiang Jiuzhou Pharmaceutical Co to be Fairly Valued.
Key valuation signals for SHSE:603456:
Days Inventory: 157.67 (17% below median its 10-year median of 189.62)
GF Value™: ¥16.43 vs. price of ¥15.18 (7.6% below fair value)
Industry Position: 4.4% below the Drug Manufacturers median (#479 of 922)
No single metric tells the full story. See the SHSE:603456 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Zhejiang Jiuzhou Pharmaceutical Co Ltd is a China-based pharmaceutical manufacturer. The company is primarily engaged in the manufacturing, research, development, and sale of active pharmaceutical ingredients, intermediates, asymmetric catalyst, and lithium battery materials. Its active pharmaceutical ingredient offerings include Carbamazepine, Duloxetine, Bezafibrate, Meropenem, Sulphadimethoxine Sodium, Oxcarbazepine, and Amprolium, among others. The firm also provides services of new drug contract development and manufacturing organization to the international pharmaceutical giant.
95GF Score
Get the complete analysis for SHSE:603456
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603456 has been successfully added to your 
